The promise of Donanemab: a new hope in the fight against Alzheimer’s
The Phase 3 study of donanemab has yielded encouraging outcomes, representing a notable advancement in the fight against Alzheimer's disease.
Lisa Genova: communicating science, one novel at a time
Lisa Genova's writings — including books like ‘Still Alice’ — give a voice to individuals who are battling chronic diseases like Alzheimer’s.